{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nKoliaraki V. et al, (2022), Nature immunology
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKorsunsky I. et al, (2022), Med (n y), 3, 481 - 518.e14
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCooles FAH. et al, (2022), Ann rheum dis, 81, 1214 - 1223
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNayar S. et al, (2022), Commun biol, 5
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nAiyegbusi OL. et al, (2022), Trials, 23
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nClark K. et al, (2022), Annals of the rheumatic diseases, 81, 495 - 496
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nPucino V. et al, (2022), Annals of the rheumatic diseases, 81, 51 - 52
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nNayar S. et al, (2022), Clinical and experimental rheumatology, 40, 74 - 74
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nNayar S. et al, (2022), Clinical and experimental rheumatology, 40, 27 - 27
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nClayton SA. et al, (2021), Sci adv, 7
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTAYLOR P. et al, (2021), Nature scientific data
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCole M. et al, (2021), Trials, 22
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFriedrich M. et al, (2021), Nat med, 27, 1970 - 1981
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBuckley CD. et al, (2021), Nat immunol, 22, 1344 - 1348
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nGe X. et al, (2021), Genome biol, 22
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nBuckley CD., (2021), European journal of immunology, 51, 18 - 18
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRayner F. et al, (2021), Bmc rheumatol, 5
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nGenovese MC. et al, (2021), Lancet rheumatology, 3, E473 - E474
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMirza M. et al, (2021), Musculoskeletal care
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBuckley CD., (2021), Nature, 593, 511 - 512
\n \n \n \n\n \n
\n \n \n